Acquisitions and Other Strategic Transactions - Advanced Radiation Therapy (Details) - Advanced Radiation Therapy, LLC $ in Millions |
May 01, 2023
USD ($)
|
|---|---|
| Asset Acquisition [Line Items] | |
| Purchase price | $ 0.8 |
| Payment period | 30 days |
| Acquired in-process research and development expense | $ 1.5 |
| First Payment | |
| Asset Acquisition [Line Items] | |
| Deferred payment | 0.5 |
| Second Payment | |
| Asset Acquisition [Line Items] | |
| Deferred payment | $ 0.8 |
| X | ||||||||||
- Definition Amount of transaction cost incurred recorded as in-process research and development costs in asset acquisition. No definition available.
|
| X | ||||||||||
- Definition Represents the period for which an asset acquisition contingent consideration is to be paid. No definition available.
|
| X | ||||||||||
- Definition Amount of contingent consideration recognized as part of consideration transferred in asset acquisition. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition The cash outflow for purchases of and capital improvements on property, plant and equipment (capital expenditures), software, and other intangible assets. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|